Press Mentions
Mentions of Bare Dermatology in the press and other mentions around the community.
Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma
FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the Two T’s in a Pod podcast and stage II melanoma survivor Teddi Mellencamp Arroyave to raise awareness around the prevention, detection and management of melanoma, the deadliest form of skin cancer. The campaign will focus on empowering patients impacted by the disease.
Bare Dermatology Expands with Opening of 9th DFW Area Location, Led by Dr. Ritu Swali
February 13, 2025 – DALLAS, Feb. 13, 2025 /PRNewswire/ — Bare Dermatology is excited to announce the opening of its ninth location at 9201 N. Central Expressway, Ste 120, Dallas, TX. Known for its commitment to high-quality care with minimal wait times, Bare Dermatology provides top-tier skincare in a welcoming environment….
Bare Dermatology Expands Across DFW Metroplex in 2024, Welcoming New Locations and Providers
DALLAS, Dec. 26, 2024 /PRNewswire/ — Bare Dermatology, a leading dermatology practice known for cutting-edge treatments and compassionate care, is celebrating significant growth in 2024. The practice has opened three new locations, welcomed expert providers, and continued its commitment to delivering high-quality dermatologic services across North Texas.
A Targeted Approach to laBCC: Innovations in Treatments for Locally Advanced Basal Cell Carcinoma
March 6, 2025 – Basal cell carcinoma or BCC is the most common cancer worldwide. But up to 10% of these cancers become locally advanced. Locally advanced basal cell carcinomas or laBCCs are much harder to treat through conventional treatment methods. ODOMZO® (sonidegib) is a prescription medicine used to treat adults with basal cell carcinoma that has come back following surgery or radiation or that cannot be treated with surgery or radiation. ODOMZO is currently the only hedgehog pathway inhibitor (HHI) proven to provide more than 2 years of tumor response in laBCC patients. Watch as Dr. Aaron Farberg and his laBCC patient Kara explore this treatment option.
Bare Dermatology Expands Across DFW Metroplex in 2024, Welcoming New Locations and Providers
DALLAS, Dec. 26, 2024 /PRNewswire/ — Bare Dermatology, a leading dermatology practice known for cutting-edge treatments and compassionate care, is celebrating significant growth in 2024. The practice has opened three new locations, welcomed expert providers, and continued its commitment to delivering high-quality dermatologic services across North Texas.
New Study Underscores Efficacy of Systematic Ultrasound Imaging in the Treatment of Nonmelanoma Skin Cancer with Image-Guided Superficial Radiation Therapy
August 26, 2024 – [Source: PR Newswire] August 26, 2024 – [Source: PR Newswire] BURR RIDGE, Ill., Aug. 26, 2024 /PRNewswire/ — SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT)
Aaron Farberg, MD: Image Guided SRT Achieves High Cure Rates in Non Melanoma Skin Cancer
September 24, 2024 – [Source: Dermatology Times] September 24, 2024 – [Source: Dermatology Times] Dermatology Times: Can you summarize the key findings of your recent study on image-guided SRT for non melanoma skin cancer? What do these results suggest about the effectiveness of this treatment?
Bare Dermatology offers cosmetic treatments in Frisco
Oct 7, 2024 – [Source: Community Impact] October 7, 2024 – [Source: Community Impact]The business offers a number of cosmetic services and general dermatology treatments for moles, rashes, eczema, psoriasis and more as well as surgical and non-surgical skin cancer treatments. This is the seventh Bare Dermatology location for the practice.
New dermatology office confirmed for Frisco Medical Pavilion II
July 13, 2023 – [Source: Dermatology Times] November 21, 2022 – [Source: Community Impact] A new dermatology care center is coming to Frisco at 12950 Dallas Parkway. Bare Dermatology signed a lease for an 11,500-square-foot space on the third floor of the upcoming Frisco Medical Pavilion II.
Maximizing Care With Nurse Practitioners and Physician Assistants
July 13, 2023 – [Source: Dermatology Times] A study led by Dermatology Times editorial board member Aaron Farberg, MD, FAAD, double-board-certified dermatologist, Mohs surgeon, and chief medical officer of Bare Dermatology in Dallas, Texas, identified a shortage of dermatologists across the United States. In a survey through the American Academy of Dermatology, data indicated that 38% of clinicians in urban areas reported a low number of dermatologists in their community.
Swedish Melanoma Detection Device To Be Piloted at Dallas-Area Bare Dermatology Clinics
September 25, 2023 – [Source: Dallas Innovates] Stockholm-based SciBase has begun piloting its FDA-approved Nevisense device in the U.S.—starting in sun-splashed markets like North Texas, Florida, and other areas “where melanoma rates are high.” SciBase announced that it’s partnering with North Texas-based Bare Dermatology—which has five offices in the Dallas area—to pilot the device at select locations.
SciBase initiates pilot with Bare Dermatology to advance skin cancer detection in Texas
September 25, 2023 – [Source: PR Newswire] SciBase Holding AB (“SciBase”) [STO:SCIB] a leading developer of augmented intelligence-based solutions for skin disorders announced today that they have entered into a collaboration agreement with Bare Dermatology to pilot Nevisense in select locations in Texas.